65
Participants
Start Date
May 28, 2020
Primary Completion Date
December 28, 2020
Study Completion Date
May 12, 2021
"Hydrous biopolymer with silver ions Argiform (HBISA) endoprosthesis of synovial fluid NOLTREX™"
If clinically indicated patients received a repeat course of NOLTREX™ (one or two weekly intra-articular injections of 4.0 NOLTREX™ at the investigator's discretion depending on the stage of OA and clinical response to treatment).
"Non-budgetary healthcare facility Railway clinical hospital n.a. Semashko N.A. at Lublino, OJSC Russian Railways", Moscow
"Clinical Diagnostic Center Ultramed, LLC", Omsk
"Private Healthcare Facilty Clinical hospital RZHD-Medicina of the city Saint-Petersburg", Saint Petersburg
"State budgetary healthcare facility of Yaroslavl Region Clinical hospital №3", Yaroslavl
Research Centre BIOFORM
INDUSTRY